Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Guidelines recommend using percutaneous endoscopic gastrostomy (PEG) for dysphagia after 2 weeks of stroke onset. We aimed to study the impact of PEG timing on outcomes in patients with ischemic stroke.

Methods: In this retrospective study of patients with ischemic stroke and PEG between 2014 and 2019, early PEG was defined as PEG tube placed within 14 days of stroke and late PEG after 14 days. Outcomes of 30-day mortality, PEG-related complications, and functional swallow recovery were compared between early and late PEG. Logistic regression model assessed factors associated with PEG timing.

Results: The median time of PEG tube placement after stroke was 10.9 days. Of the 161 included patients, 60.9% had early PEG, and its associated patient factors were nursing facility discharge (adjusted odds ratio (OR): 3.4, confidence interval (CI): 1.48 - 7.82) and infection (OR: 0.32, CI: 0.139 - 0.178). Late PEG had 3.27 times greater odds of swallowing recovery, but mortality and complications were not significantly different between early and late PEG.

Conclusions: Skilled nursing facility disposition and lack of infection were predictors of early PEG, constituting the majority of PEG placed for ischemic stroke-related dysphagia. Although better odds of swallowing recovery were seen with late PEG, likely implicating better patient selection, overall, the timing of PEG tube placement did not impact short-term mortality and complications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10769609PMC
http://dx.doi.org/10.14740/gr1653DOI Listing

Publication Analysis

Top Keywords

late peg
16
peg
15
early peg
12
peg tube
12
timing outcomes
8
percutaneous endoscopic
8
endoscopic gastrostomy
8
ischemic stroke
8
patients ischemic
8
early late
8

Similar Publications

Background: Standard adjuvant chemoradiotherapy (60-66 Gy) following surgery for HPV-associated oropharyngeal squamous cell carcinoma has excellent oncological control but high treatment morbidity. We aimed to compare toxicity of a 30-36 Gy regimen of de-escalated adjuvant radiotherapy and standard of care treatment.

Methods: We did this phase 3, open-label, randomised controlled trial in two academic sites in the USA.

View Article and Find Full Text PDF

Rational design of PEGylated nanogels: optimization of degree of PEGylation and development of a novel enzyme-responsive grafted layer.

Int J Pharm

August 2025

Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, 107 W Dean Keeton Street Stop C0800, Austin, TX 78712, USA; McKetta Department of Chemical Engineering, The University of Texas at Austin, 200 E. Dean Keeton St. Stop C0400, Austin, TX 78712, USA

Since its ideation in the late 1960 s, PEGylation, or the covalent linking of polyethylene glycol (PEG) to biological molecules, has emerged as a prominent strategy for overcoming numerous barriers encountered in the biological milieu. PEG conjugation can increase circulation time, reduce both protein adsorption & phagocytic clearance, and increase stability. While many of these PEGylated nanotherapeutics have seen widespread usage and market success, others fail to reach the public due to a lack of efficacy and unintended immunogenicity.

View Article and Find Full Text PDF

[History of Internal Fixation of Fractures in the Czech Lands].

Acta Chir Orthop Traumatol Cech

July 2025

Anatomicky ustav 1. lekarske fakulty Univerzity Karlovy, Praha.

The beginnings of osteosynthesis (OS) in the Czech lands, dating back to the second half of the 19th century, are associated with the German surgeons W. Heine and C. Gussenbauer working in Prague.

View Article and Find Full Text PDF

The transmembrane integrin, very late antigen-4 (VLA-4), which is a critical integrin involved in promoting tumor progression, angiogenesis, and metastasis, is overexpressed in metastatic melanoma. The peptidomimetic LLP2A has a high binding affinity to VLA-4 and is used as a radiopharmaceutical targeting agent for imaging and therapy. Previous studies demonstrated that the albumin-binding compound, [Lu]Lu-DOTAGA-pIBA-PEG-LLP2A, significantly improved tumor retention and blood circulation time but resulted in lower tumor-to-nontumor tissue ratios compared to the nonalbumin-binding compound, [Lu]Lu-DOTAGA-PEG-LLP2A.

View Article and Find Full Text PDF

Percutaneous endoscopic gastrostomy (PEG), became a common option for extended enteral nutritional support. Placing a PEG tube is generally considered as a safe procedure, Nevertheless, mild to severe complications may occur. A 73-year-old female presented to our outpatient clinic with nausea, vomiting and weight loss.

View Article and Find Full Text PDF